Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS
Jad Othman(King's College London), Richard Dillon(King's College London), Pramila Krishnamurthy(King's College London), Nicole Fowler(Royal Cornwall Hospital Trust), Johnathon Elliot(The Christie Hospital), Herng Mak(University Hospitals Sussex NHS Foundation Trust), Paolo Gallipoli(Wellcome/MRC Cambridge Stem Cell Institute), Jamila Bashir(University Hospitals of Derby and Burton NHS Foundation Trust), Jenny O’Nions(University College London Hospitals NHS Foundation Trust), Victoria Campbell(Western General Hospital), Pallavi Kalkur(Southend Hospital), Francesca Hogan(University Hospital of Wales), Ho Pui Jeff Lam(University College London Hospitals NHS Foundation Trust), Edward Belsham(Portsmouth Hospitals NHS Trust), Jennifer Vidler(King's College Hospital), Sarah Leong(University College London Hospitals NHS Foundation Trust), Duncan Murray(University Hospitals Coventry and Warwickshire NHS Trust), Deepak Mannari(Musgrove Park Hospital), Mike Dennis(The Christie NHS Foundation Trust), Anjum Khan(Leeds Teaching Hospitals NHS Trust), Shabnam Banerjee(Barking, Havering And Redbridge University Hospitals NHS Trust), Priyanka Mehta, Mariam Amer(University Hospital Southampton NHS Foundation Trust), Srinivas Pillai(University Hospitals of North Midlands NHS Trust), Francesca Crolla(Musgrove Park Hospital), Emily Sutherland(City Hospital), John Laurie(Worthing Hospital), Kathryn Fleming(University Hospitals Sussex NHS Foundation Trust), Vidhya Murthy(NIHR Surgical Reconstruction and Microbiology Research Centre), Farooq Wandroo(Sandwell & West Birmingham Hospitals NHS Trust), Richard Whitmill(New Cross Hospital), Thomas Taylor(Nottingham University Hospitals NHS Trust), Sofia Galli(Frimley Park Hospital), Maryam Shahidianakbar, Thishakya Wickramaratne(Blackpool Teaching Hospitals NHS Foundation Trust), Rui Zhao(Torbay Hospital), Heba Yassin(Queen Mary University of London), Anne‐Louise Latif(Queen Elizabeth University Hospital), Georgina Clarke(James Cook University Hospital), Angela Collins(Norfolk and Norwich University Hospitals NHS Foundation Trust), Faisal Basheer, I. Ben Abdallah(Leeds Teaching Hospitals NHS Trust), Raymond Dang(James Cook University Hospital), Michael J. Austin(Queen Mary University of London)
Cited by 36
Related Papers
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
|Cell Reports|2016|834
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714